Literature DB >> 2547767

Identification of receptors for platelet-activating factor in rat Kupffer cells.

W Chao1, H Liu, M DeBuysere, D J Hanahan, M S Olson.   

Abstract

Ligand binding studies demonstrated that isolated rat Kupffer cells possess high affinity binding sites for platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine, AGEPC). AGEPC binding reached saturation within 10 min at 25 degrees C and was reversible. A Scatchard analysis revealed a single class of AGEPC receptors numbering about 10,600 sites/cell and possessing a dissociation constant of 0.45 nM. Similar values for the dissociation constant for AGEPC (0.12 and 0.34 nM) were obtained independently by kinetic analysis of specific AGEPC binding. AGEPC binding was stereospecific and was inhibited by Zn2+ and AGEPC receptor antagonists including BN52021 and U66985. The AGEPC receptor was functionally active since it was shown to mediate arachidonic acid release and eicosanoid production in Kupffer cells, and these events were inhibited by AGEPC receptor antagonist BN52021. The receptor-mediated arachidonic acid release was extracellular calcium-dependent and was abolished by calcium channel blocker prenylamine and by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid, indicating that calcium influx through a receptor-regulated calcium channel in the plasma membrane is involved in the AGEPC-induced arachidonic acid release. It is suggested that rat Kupffer cells have specific and functionally active AGEPC receptors which are involved in signaling mechanisms which govern the production of several other autacoid-type mediators in the liver.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547767

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

2.  Metabolic effects of platelet-activating factor in rats in vivo. Stimulation of hepatic glycogenolysis and lipogenesis.

Authors:  R D Evans; V Ilic; D H Williamson
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

3.  Protein tyrosine phosphorylation and regulation of the receptor for platelet-activating factor in rat Kupffer cells. Effect of sodium vanadate.

Authors:  W Chao; H Liu; D J Hanahan; M S Olson
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

4.  Arachidonic acid mobilization in P388D1 macrophages is controlled by two distinct Ca(2+)-dependent phospholipase A2 enzymes.

Authors:  J Balsinde; S E Barbour; I D Bianco; E A Dennis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

5.  Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Involvement of mannose receptors, peptide-leukotrienes and prostaglandins.

Authors:  K Kimura; M Shiota; K Mochizuki; M Ohta; T Sugano
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

6.  Platelet-activating factor inactivator (rPAF-AH) enhances liver's recovery after paracetamol intoxication.

Authors:  A D Grypioti; G Kostopanagiotou; M Mykoniatis
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

7.  Platelet activating factor (PAF) antagonism with ginkgolide B protects the liver against acute injury. importance of controlling the receptor of PAF.

Authors:  Agni D Grypioti; Georgia Kostopanagiotou; Constantinos A Demopoulos; Anastasios Roussos; Michael Mykoniatis
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

8.  Recombinant platelet-activating factor-acetylhydrolase attenuates paracetamol-induced liver oxidative stress, injury, and regeneration.

Authors:  A D Grypioti; M Mykoniatis; C A Demopoulos; G Kostopanagiotou
Journal:  Dig Dis Sci       Date:  2006-12-08       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.